Loading
Latest filing published 18 Sept 2024 for Alimera Sciences INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Philip Ashman (senior executive) discloses dealings in Alimera Sciences Inc to SEC (Form 4). Between 20 January 2017 and 16 September 2024, the trades on record add up to 23 filings.
In open-market terms, that means 1 purchase worth €5,035 on one side and 5 sales worth €51k on the other. On balance, insiders were net sellers of €46k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 16 share grants.
The record was last updated on 18 September 2024 with a transaction in Alimera Sciences Inc. The clock since the last published purchase (5 November 2020) now reads 2,179 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations